TECHNOLOGY THAT SHALL REDEFINE THE PERFORMANCE OF DRUG ELUTING STENTS
SUMMIT OF DELIVERY SYSTEMS
Probucol for Optimal Drug Release
- Probucol obviates the Polymer related side effects of Acute Thrombogenicity, Inflammation, Delayed arterial healing.
- Due to its high lipophilicity it facilitates retardation of Everolimus release in similar manner to that achieved by polymers.
- Probucol and Everolimus co-release upto 80% in 28 days.*
- Probucol is a well studied drug at a much higher does (upto 500 mg) oral dosage with proven safety.
ORDERING INFORMATION
COMPLIANCE CHART
